179 related articles for article (PubMed ID: 19193883)
41. Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT.
Cremona ML; Matthies HJ; Pau K; Bowton E; Speed N; Lute BJ; Anderson M; Sen N; Robertson SD; Vaughan RA; Rothman JE; Galli A; Javitch JA; Yamamoto A
Nat Neurosci; 2011 Apr; 14(4):469-77. PubMed ID: 21399631
[TBL] [Abstract][Full Text] [Related]
42. Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine.
Wheeler DS; Underhill SM; Stolz DB; Murdoch GH; Thiels E; Romero G; Amara SG
Proc Natl Acad Sci U S A; 2015 Dec; 112(51):E7138-47. PubMed ID: 26553986
[TBL] [Abstract][Full Text] [Related]
43. Sequence determinants of the Caenhorhabditis elegans dopamine transporter dictating in vivo axonal export and synaptic localization.
Robinson SB; Hardaway JA; Hardie SL; Wright J; Glynn RM; Bermingham DP; Han Q; Sturgeon SM; Freeman P; Blakely RD
Mol Cell Neurosci; 2017 Jan; 78():41-51. PubMed ID: 27913309
[TBL] [Abstract][Full Text] [Related]
44. Genetic complementation screen identifies a mitogen-activated protein kinase phosphatase, MKP3, as a regulator of dopamine transporter trafficking.
Mortensen OV; Larsen MB; Prasad BM; Amara SG
Mol Biol Cell; 2008 Jul; 19(7):2818-29. PubMed ID: 18434601
[TBL] [Abstract][Full Text] [Related]
45. Targeting of dopamine transporter to filopodia requires an outward-facing conformation of the transporter.
Ma S; Cheng MH; Guthrie DA; Newman AH; Bahar I; Sorkin A
Sci Rep; 2017 Jul; 7(1):5399. PubMed ID: 28710426
[TBL] [Abstract][Full Text] [Related]
46. N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux.
Khoshbouei H; Sen N; Guptaroy B; Johnson L'; Lund D; Gnegy ME; Galli A; Javitch JA
PLoS Biol; 2004 Mar; 2(3):E78. PubMed ID: 15024426
[TBL] [Abstract][Full Text] [Related]
47. The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain.
Lee FJ; Pristupa ZB; Ciliax BJ; Levey AI; Niznik HB
J Biol Chem; 1996 Aug; 271(34):20885-94. PubMed ID: 8702845
[TBL] [Abstract][Full Text] [Related]
48. Trafficking of dopamine transporters in psychostimulant actions.
Zahniser NR; Sorkin A
Semin Cell Dev Biol; 2009 Jun; 20(4):411-7. PubMed ID: 19560046
[TBL] [Abstract][Full Text] [Related]
49. Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter.
Wersinger C; Sidhu A
Biochemistry; 2005 Oct; 44(41):13612-24. PubMed ID: 16216085
[TBL] [Abstract][Full Text] [Related]
50. Dopamine transporter is enriched in filopodia and induces filopodia formation.
Caltagarone J; Ma S; Sorkin A
Mol Cell Neurosci; 2015 Sep; 68():120-30. PubMed ID: 25936602
[TBL] [Abstract][Full Text] [Related]
51. Ctr9, a Protein in the Transcription Complex Paf1, Regulates Dopamine Transporter Activity at the Plasma Membrane.
De Gois S; Slama P; Pietrancosta N; Erdozain AM; Louis F; Bouvrais-Veret C; Daviet L; Giros B
J Biol Chem; 2015 Jul; 290(29):17848-17862. PubMed ID: 26048990
[TBL] [Abstract][Full Text] [Related]
52. Regulated rapid round trips: Endocytotic cycling of the dopamine transporter shapes motor learning.
Freissmuth M
J Biol Chem; 2023 Apr; 299(4):104618. PubMed ID: 36935007
[TBL] [Abstract][Full Text] [Related]
53. Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter.
Torres GE; Carneiro A; Seamans K; Fiorentini C; Sweeney A; Yao WD; Caron MG
J Biol Chem; 2003 Jan; 278(4):2731-9. PubMed ID: 12429746
[TBL] [Abstract][Full Text] [Related]
54. Iron chelation down-regulates dopamine transporter expression by decreasing mRNA stability and increasing endocytosis in N2a cells.
Hegde NV; Jensen GL; Unger EL
Exp Cell Res; 2011 Feb; 317(4):405-12. PubMed ID: 21147099
[TBL] [Abstract][Full Text] [Related]
55. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
56. Truncation of human dopamine transporter by protease calpain.
Franekova V; Baliova M; Jursky F
Neurochem Int; 2008 Jun; 52(8):1436-41. PubMed ID: 18468730
[TBL] [Abstract][Full Text] [Related]
57. Palmitoylation controls dopamine transporter kinetics, degradation, and protein kinase C-dependent regulation.
Foster JD; Vaughan RA
J Biol Chem; 2011 Feb; 286(7):5175-86. PubMed ID: 21118819
[TBL] [Abstract][Full Text] [Related]
58. Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters.
Daniels GM; Amara SG
J Biol Chem; 1999 Dec; 274(50):35794-801. PubMed ID: 10585462
[TBL] [Abstract][Full Text] [Related]
59. Clustered Kv2.1 decreases dopamine transporter activity and internalization.
Lebowitz JJ; Pino JA; Mackie PM; Lin M; Hurst C; Divita K; Collins AT; Koutzoumis DN; Torres GE; Khoshbouei H
J Biol Chem; 2019 Apr; 294(17):6957-6971. PubMed ID: 30824538
[TBL] [Abstract][Full Text] [Related]
60. Interrelation of dopamine transporter oligomerization and surface presence as studied with mutant transporter proteins and amphetamine.
Li Y; Cheng SY; Chen N; Reith ME
J Neurochem; 2010 Aug; 114(3):873-85. PubMed ID: 20492355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
